ArticleCancer pathogenesis and therapy2023

Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis.

LaYow C Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.